by Vandana Singh | Jan 7, 2026 | General
Vera Therapeutics Inc. (NASDAQ:VERA) stock rose Wednesday after the U.S. Food and Drug Administration (FDA) accepted the company’s atacicept Biologics License Application (BLA) for Priority Review. The application covers adults with immunoglobulin A nephropathy...
by Avi Kapoor | Jan 7, 2026 | General
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining more than 150 points on Wednesday. The Dow traded down 0.17% to 49,380.41 while the NASDAQ gained 0.71% to 23,714.14. The S&P 500 also rose, gaining, 0.27% to 6,963.78. Check This...
by Surbhi Jain | Jan 7, 2026 | General
Oracle Corp’s (NYSE:ORCL) chart just turned awkward — and the timing couldn’t be worse. The tech company’s stock printed a death cross, with its 50-day moving average slipping below the 200-day, a technical setup traders associate with fading momentum...
by Anusuya Lahiri | Jan 7, 2026 | General
Micron Technology Inc. (NASDAQ:MU) said on Wednesday that it will officially break ground on its massive semiconductor manufacturing site in Onondaga County, New York, on January 16, 2026. After completing environmental reviews and securing required permits, Micron is...
by Alex Perry | Jan 7, 2026 | General
Shares of Genmab (NASDAQ:GMAB) are rising Wednesday after the Danish biotechnology company said it would partner with AI company Anthropic. What’s Going On With The Partnership? Genmab, which develops several late-stage investigational antibody medicines across solid...
Recent Comments